Ana Abecasis
Has grant
Assistant Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
MARVEL: Minimizing the emergence and dissemination of HIV-1 drug resistance in PALOPs through an evidence-based portable high-throughput sequencing and computational approach.
Open Date: 2022-01-01
Close Date:
Grant: Close
EUCARE: European Cohorts of Patients and Schools to Advance Response to Epidemics
Open Date: 2021-10-01
Close Date:
Grant: Close
VAX-TRUST: Addressing vaccine hesitancy in Europe
Open Date: 2021-03-01
Close Date:
Grant: Close
Determinantes e necessidades de saúde das crianças migrantes num contexto de pandemia: Um estudo longitudinal para a Região de Lisboa e Vale do Tejo
Open Date: 2021-02-01
Close Date: 2024-01-31
Grant: Close
Resposta à pandemia de Covid-19 num contexto de desigualdades sociais em saúde: um estudo transversal na população nativa e imigrante da Amadora
Open Date: 2020-05-01
Close Date:
Articles (15)
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Introduction: Access to antiretroviral treatment (ART) is increasingly available worldwide; however, the number of patients lost to follow-up and number of treatment failures continue to challenge most African countries. Objectives: To analyse the retention in clinical care and the virological response and their associated factors of HIV-1 patients from the Maputo Military Hospital (MMH). Methods: A cross-sectional observational study was conducted to analyse data from patients who started ART between 2016 and 2018 in the MMH. Results: At the end of 12 months, 75.1% of 1247 patients were active on clinical follow-up and 16.8% had suspected virologic failure (VL > 1000 copies/mm3). Patients younger than 40 years old were more likely to be lost to follow-up when compared to those aged >50 years old, as well as patients who were unemployed and patients with a CD4 count < 350 cells/mm3. Patients with haemoglobin levels lower than 10 g/dL and with a CD4 count < 350 cells/mm3 were more likely to have virological failure. Conclusions: We have identified clinical and sociodemographic determinants of loss to follow-up and in the development of virological failure for HIV-positive patients in clinical care in the MMH. Therefore, HIV programs must consider these factors to increase the screening of patients at high risk of poor outcomes and particularly to strengthen adherence counselling programs.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (22)
Christian Eggeling
Leibniz Institute of Photonic Technology
Ahmed Nabil Shaaban
Lecturer of Econometrics and Biostatistics
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical
Maurizio Zazzi
University of Siena
Claudia Claus
Leipzig University
Marta Pingarilho
-
Sofia Paraskevopoulou
Robert Koch Institute
Caroline C. Friedel
Professor
Ludwig-Maximilians-Universität München
Pieter Libin
Professor at Vrije Universiteit Brussel
Vrije Universiteit Brussel
Simon Dellicour
Université libre de Bruxelles
Andrea Torneri
Assistant Professor
Hasselt University
Ana Lúcia Teixeira
Professora auxiliar
Faculdade de Ciências da Universidade de Lisboa
Shoichi Sakaguchi
Assistant professor
Osaka Medical and Pharmaceutical University
Stefanie Deinhardt‐Emmer
-
Robert W. Shafer
Stanford University
Maria do Rosário Oliveira Martins
Universidade de Aveiro
Luís Varandas
Universidade de Aveiro
Manja Marz
Full Professorship for High Throughput Sequencing Analysis
Friedrich Schiller University Jena
Artem Babaian
Assistant Professor
University of Toronto
Soo-Yon Rhee
Stanford University
Lia van der Hoek
Associate professor
Academic Medical Center
Li Deng
Professor
Technical University of Munich
Cruz Sebastião
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical
Make your next move.
Prepare your application
Review drafts before you send them.